Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation

To examine the risk of treatment emergent, cardiovascular serious adverse events associated with varenicline use for tobacco cessation. Meta-analysis comparing study effects using four summary estimates. Medline, Cochrane Library, online clinical trials registries, and reference lists of identified articles. Judith Prochaska, PhD, MPH, is Associate Professor in the Department of Medicine at Stanford University with the Stanford Prevention Research Center.

Publication

 

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error: Faculti Content is protected. Please check our Privacy Policy and Terms and Conditions.

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×